VF
PBMWW

Virtu Financial’s Psyence Biomedical Warrant PBMWW Stock Holding History

Virtu Financial’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,853
Closed -$1K – 2344
2026
Q1 		$1K Buy
27,853
+14,589
+110% +$280 ﹤0.01% 1555
2025
Q4 		$0 Sell
13,264
-1,988
-13% -$50 ﹤0.01% 2332
2025
Q3 		$0 Buy
+15,252
New +$384 ﹤0.01% 2183
2025
Q2 		– Sell
-76,322
Closed -$1K – 2109
2025
Q1 		$1K Buy
76,322
+25,771
+51% +$490 ﹤0.01% 1278
2024
Q4 		$1K Buy
+50,551
New +$672 ﹤0.01% 1467

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Virtu Financial's PBMWW Position: Q2 2026 in Review

Virtu Financial sold out of Psyence Biomedical Warrant (PBMWW) in Q2 2026, closing a stake of 27,853 shares — an estimated $1K sold.

Virtu Financial first reported a position in PBMWW in Q4 2024 and held it in 5 quarters. The position peaked at $1K in Q1 2026. 18 funds tracked by Wall St. Rank hold PBMWW as of Q2 2026.

  • Virtu Financial reported no remaining Psyence Biomedical Warrant position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 27,853 Psyence Biomedical Warrant shares in Q2 2026, an estimated $1K.
  • Virtu Financial first reported a position in Psyence Biomedical Warrant in Q4 2024 and held it in 5 quarters.
  • Virtu Financial's Psyence Biomedical Warrant position peaked at $1K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.